Beqalzi

News

BeOne gets the nod for BCL2 inhibitor Beqalzi in mantle cell lymphoma, while Taiho's Inqovi has acute myeloid leukaemia added to its label.

News

Pfizer's second-quarter results update is headlined by news of an additional $2.5 billion in cost-cutting initiatives.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.